iifl-logo

Link Pharma Chem Ltd Board Meeting

Add as a Preferred Source on Google
27
(-1.10%)
Mar 4, 2026|12:00:00 AM

Link Pharma Chem CORPORATE ACTIONS

05/03/2025calendar-icon
05/03/2026calendar-icon
PurposeBoard Meetings DateAnnouncement Date
Board Meeting14 Feb 20267 Feb 2026
Link Pharma Chem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 inter alia to consider and approve Link Pharma chem Ltd has informed BSE that the meeting of Board of Directors of company is scheduled on 14/02/2026 inter-alia to consider and approve Unaudited financial results for Quarter and nine months period ended on 31st December 2025. We herewith submit unaudited financial result for the quarter and Nine months ended on 31st December, 2025 We herewith submit unaudited financial result for the quarter and nine months ended on 31st December, 2025 (As Per BSE Announcement Dated on:14.02.2026)
Board Meeting13 Nov 20256 Nov 2025
Link Pharma Chem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 inter alia to consider and approve Unaudited Financial Results for the quarter and half year ended September 30 2025. Outcome of Board Meeting held on Thursday, 13th November, 2025. (As per BSE Announcement dated on: 13.11.2025)
Board Meeting1 Aug 202524 Jul 2025
Link Pharma Chem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2025 inter alia to consider and approve Unaudited Financial Results for the quarter ended June 30 2025. Outcome of Board Meeting held on 01st August, 2025. Unaudited Financial result of the company for the quarter ended June 30, 2025. (As Per BSE Announcement Dated on :01.08.2025)
Board Meeting27 May 202517 May 2025
Link Pharma Chem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2025 inter alia to consider and approve Audited financial results for the quarter and financial year ended on March 31 2025 under Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. Outcome of Board Meeting held on 27th May, 2025. (As Per BSE Announcement Dated on :27.05.2025)

Link Pharma Chem: Related News

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.